Published in Circ Res on May 28, 2004
Cardiac myosin-binding protein-C phosphorylation and cardiac function. Circ Res (2005) 2.67
Pre-clinical diastolic dysfunction. J Am Coll Cardiol (2013) 2.39
Three-dimensional structure of vertebrate cardiac muscle myosin filaments. Proc Natl Acad Sci U S A (2008) 2.39
Sarcomeric proteins and familial hypertrophic cardiomyopathy: linking mutations in structural proteins to complex cardiovascular phenotypes. Heart Fail Rev (2005) 2.10
Top-down high-resolution mass spectrometry of cardiac myosin binding protein C revealed that truncation alters protein phosphorylation state. Proc Natl Acad Sci U S A (2009) 2.10
Muscle giants: molecular scaffolds in sarcomerogenesis. Physiol Rev (2009) 1.92
Cardiac myosin-binding protein C decorates F-actin: implications for cardiac function. Proc Natl Acad Sci U S A (2008) 1.84
Direct visualization of myosin-binding protein C bridging myosin and actin filaments in intact muscle. Proc Natl Acad Sci U S A (2011) 1.83
Multiplex kinase signaling modifies cardiac function at the level of sarcomeric proteins. J Biol Chem (2008) 1.76
Ablation of myosin-binding protein-C accelerates force development in mouse myocardium. Biophys J (2006) 1.69
Understanding the organisation and role of myosin binding protein C in normal striated muscle by comparison with MyBP-C knockout cardiac muscle. J Mol Biol (2008) 1.57
Protein kinase A-mediated phosphorylation of cMyBP-C increases proximity of myosin heads to actin in resting myocardium. Circ Res (2008) 1.55
Distinct sarcomeric substrates are responsible for protein kinase D-mediated regulation of cardiac myofilament Ca2+ sensitivity and cross-bridge cycling. J Biol Chem (2009) 1.47
Orientation of myosin binding protein C in the cardiac muscle sarcomere determined by domain-specific immuno-EM. J Mol Biol (2014) 1.43
Electron microscopy and 3D reconstruction of F-actin decorated with cardiac myosin-binding protein C (cMyBP-C). J Mol Biol (2011) 1.37
Comprehensive analysis of protein modifications by top-down mass spectrometry. Circ Cardiovasc Genet (2011) 1.34
Radial displacement of myosin cross-bridges in mouse myocardium due to ablation of myosin binding protein-C. J Mol Biol (2006) 1.33
Myosin binding protein C interaction with actin: characterization and mapping of the binding site. J Biol Chem (2010) 1.27
Cardiac myosin binding protein-C is a potential diagnostic biomarker for myocardial infarction. J Mol Cell Cardiol (2011) 1.27
Obscurin interacts with a novel isoform of MyBP-C slow at the periphery of the sarcomeric M-band and regulates thick filament assembly. Mol Biol Cell (2009) 1.23
Quantitative comparison of sarcomeric phosphoproteomes of neonatal and adult rat hearts. Am J Physiol Heart Circ Physiol (2008) 1.20
Phosphoregulation of Cardiac Inotropy via Myosin Binding Protein-C During Increased Pacing Frequency or β1-Adrenergic Stimulation. Circ Heart Fail (2015) 1.20
Identification of cardiac myosin-binding protein C as a candidate biomarker of myocardial infarction by proteomics analysis. Mol Cell Proteomics (2009) 1.18
Signaling and myosin-binding protein C. J Biol Chem (2011) 1.18
Cardiac myosin binding protein-C: redefining its structure and function. Biophys Rev (2012) 1.15
Cardiac myosin binding protein-C modulates actomyosin binding and kinetics in the in vitro motility assay. J Mol Cell Cardiol (2008) 1.15
Myosin binding protein-C phosphorylation is the principal mediator of protein kinase A effects on thick filament structure in myocardium. J Mol Cell Cardiol (2012) 1.13
Roles for cardiac MyBP-C in maintaining myofilament lattice rigidity and prolonging myosin cross-bridge lifetime. Biophys J (2011) 1.11
Thick filament proteins and performance in human heart failure. Heart Fail Rev (2005) 1.11
Myosin-binding protein C displaces tropomyosin to activate cardiac thin filaments and governs their speed by an independent mechanism. Proc Natl Acad Sci U S A (2014) 1.10
Localization of the binding site of the C-terminal domain of cardiac myosin-binding protein-C on the myosin rod. Biochem J (2007) 1.08
The cAMP binding protein Epac regulates cardiac myofilament function. Proc Natl Acad Sci U S A (2009) 1.05
The structure of isolated cardiac Myosin thick filaments from cardiac Myosin binding protein-C knockout mice. Biophys J (2007) 1.05
Myosin binding protein-C slow: an intricate subfamily of proteins. J Biomed Biotechnol (2010) 1.02
Cytoplasmic Ig-domain proteins: cytoskeletal regulators with a role in human disease. Cell Motil Cytoskeleton (2009) 1.02
Receptor-independent cardiac protein kinase Calpha activation by calpain-mediated truncation of regulatory domains. Circ Res (2010) 1.00
Effects of contractile protein phosphorylation on force development in permeabilized rat cardiac myocytes. Basic Res Cardiol (2007) 0.95
Novel control of cardiac myofilament response to calcium by S-glutathionylation at specific sites of myosin binding protein C. Front Physiol (2013) 0.95
Myosin binding protein-C: a regulator of actomyosin interaction in striated muscle. J Biomed Biotechnol (2011) 0.95
Cardiac myosin binding protein-C restricts intrafilament torsional dynamics of actin in a phosphorylation-dependent manner. Proc Natl Acad Sci U S A (2012) 0.94
Cardiac myosin binding protein-C as a central target of cardiac sarcomere signaling: a special mini review series. Pflugers Arch (2013) 0.93
Cardiac myosin binding protein-C is essential for thick-filament stability and flexural rigidity. Biophys J (2009) 0.92
N-terminal phosphorylation of cardiac troponin-I reduces length-dependent calcium sensitivity of contraction in cardiac muscle. J Physiol (2012) 0.92
Identification of CIITA regulated genetic module dedicated for antigen presentation. PLoS Genet (2008) 0.91
Functional dissection of myosin binding protein C phosphorylation. J Mol Cell Cardiol (2013) 0.91
Cardiac Myosin-binding protein C modulates the tuning of the molecular motor in the heart. Biophys J (2008) 0.90
Altered contractility of skeletal muscle in mice deficient in titin's M-band region. J Mol Biol (2009) 0.89
Zebrafish cardiac muscle thick filaments: isolation technique and three-dimensional structure. Biophys J (2014) 0.87
Modulation of striated muscle contraction by binding of myosin binding protein C to actin. Bioarchitecture (2011) 0.87
Mendelian-inherited heart disease: a gateway to understanding mechanisms in heart disease Update on work done at the University of Stellenbosch. Cardiovasc J Afr (2009) 0.86
Expression patterns of cardiac myofilament proteins: genomic and protein analysis of surgical myectomy tissue from patients with obstructive hypertrophic cardiomyopathy. Circ Heart Fail (2009) 0.86
Top-down Proteomics: Technology Advancements and Applications to Heart Diseases. Expert Rev Proteomics (2016) 0.86
Screening mutations in myosin binding protein C3 gene in a cohort of patients with Hypertrophic Cardiomyopathy. BMC Med Genet (2010) 0.86
Axial distribution of myosin binding protein-C is unaffected by mutations in human cardiac and skeletal muscle. J Muscle Res Cell Motil (2012) 0.85
MYBPC3's alternate ending: consequences and therapeutic implications of a highly prevalent 25 bp deletion mutation. Pflugers Arch (2013) 0.85
Sarcomeric protein isoform transitions in cardiac muscle: a journey to heart failure. Biochim Biophys Acta (2014) 0.84
Orientation of the N- and C-terminal lobes of the myosin regulatory light chain in cardiac muscle. Biophys J (2015) 0.84
Phosphorylation and calcium antagonistically tune myosin-binding protein C's structure and function. Proc Natl Acad Sci U S A (2016) 0.84
Cardiac myosin-binding protein-C is a critical mediator of diastolic function. Pflugers Arch (2014) 0.84
Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues. Adv Drug Deliv Rev (2015) 0.83
The motif of human cardiac myosin-binding protein C is required for its Ca2+-dependent interaction with calmodulin. J Biol Chem (2012) 0.83
Structure, sarcomeric organization, and thin filament binding of cardiac myosin-binding protein-C. Pflugers Arch (2014) 0.82
Tropomyosin dephosphorylation results in compensated cardiac hypertrophy. J Biol Chem (2012) 0.81
Enhanced cardiac function in Gravin mutant mice involves alterations in the β-adrenergic receptor signaling cascade. PLoS One (2013) 0.81
Top-down mass spectrometry of cardiac myofilament proteins in health and disease. Proteomics Clin Appl (2014) 0.81
Proteomic analysis of mitochondrial proteins in a mouse model of type 2 diabetes. Cardiovasc J Afr (2010) 0.81
The effect of disease on human cardiac protein expression profiles in paired samples from right and left ventricles. Clin Proteomics (2014) 0.80
Stability and kinetic properties of C5-domain from myosin binding protein C and its mutants. Biophys J (2007) 0.80
The AP-1 transcription factor c-Jun prevents stress-imposed maladaptive remodeling of the heart. PLoS One (2013) 0.80
Cardiac myosin binding protein C regulates postnatal myocyte cytokinesis. Proc Natl Acad Sci U S A (2015) 0.80
Phosphorylation of contractile proteins in response to alpha- and beta-adrenergic stimulation in neonatal cardiomyocytes. Transl Res (2010) 0.79
Cardiac myosin binding protein C and MAP-kinase activating death domain-containing gene polymorphisms and diastolic heart failure. PLoS One (2012) 0.79
Molecular modeling of disease causing mutations in domain C1 of cMyBP-C. PLoS One (2013) 0.77
Two novel mutations of the MYBPC3 gene identified in Chinese families with hypertrophic cardiomyopathy. Can J Cardiol (2010) 0.77
Molecular Screen Identifies Cardiac Myosin-Binding Protein-C as a Protein Kinase G-Iα Substrate. Circ Heart Fail (2015) 0.76
The cMyBP-C HCM variant L348P enhances thin filament activation through an increased shift in tropomyosin position. J Mol Cell Cardiol (2015) 0.76
Familial hypertrophic cardiomyopathy associated with a new mutation in gene MYBPC3. Clin Case Rep (2017) 0.75
Distinct contributions of the thin and thick filaments to length-dependent activation in heart muscle. Elife (2017) 0.75
Phosphorylation of cardiac myosin binding protein C releases myosin heads from the surface of cardiac thick filaments. Proc Natl Acad Sci U S A (2017) 0.75
Determination of AMP-activated protein kinase phosphorylation sites in recombinant protein expressed using the pET28a vector: a cautionary tale. Protein Expr Purif (2009) 0.75
Differences between cardiac and skeletal troponin interaction with the thin filament probed by troponin exchange in skeletal myofibrils. Biophys J (2009) 0.75
Rate-dependent force, intracellular calcium, and action potential voltage alternans are modulated by sarcomere length and heart failure induced-remodeling of thin filament regulation in human heart failure: A myocyte modeling study. Prog Biophys Mol Biol (2015) 0.75
Force development and intracellular Ca(2+) in intact cardiac muscles from gravin mutant mice. Eur J Pharmacol (2017) 0.75
Analyzing pathogenic mutations of C5 domain from cardiac myosin binding protein C through MD simulations. Eur Biophys J (2008) 0.75
Molecular Convergent Evolution of the MYBPC2 Gene Among Three High-Elevation Amphibian Species. J Mol Evol (2017) 0.75
Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet (2010) 23.08
Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature (2010) 20.01
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25
Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet (2009) 12.44
Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet (2012) 12.10
Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N Engl J Med (2009) 8.73
Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet (2012) 7.59
Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging. J Am Coll Cardiol (2005) 5.63
Loss-of-function mutations in APOC3, triglycerides, and coronary disease. N Engl J Med (2014) 5.47
Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA (2009) 5.32
Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies. Lancet (2010) 5.31
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J (2014) 5.21
Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet (2009) 4.97
Inactivating mutations in NPC1L1 and protection from coronary heart disease. N Engl J Med (2014) 4.94
Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet (2012) 4.73
Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet (2012) 4.63
A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet (2012) 4.37
Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p. Hum Mol Genet (2007) 4.09
Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways. Diabetes (2010) 4.07
Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail (2010) 3.90
Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease. N Engl J Med (2016) 3.88
Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure. Nat Genet (2011) 3.40
Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat Genet (2013) 3.25
Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet (2012) 3.21
Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma. Nat Genet (2011) 3.18
Modernising medical careers, medical training application service, and the postgraduate medical education and training board: time for the emperors to don their clothes. Lancet (2007) 3.12
Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet (2012) 3.04
Myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy. Circ Cardiovasc Imaging (2012) 3.01
FTO genotype is associated with phenotypic variability of body mass index. Nature (2012) 2.77
Four paraoxonase gene polymorphisms in 11212 cases of coronary heart disease and 12786 controls: meta-analysis of 43 studies. Lancet (2004) 2.55
The genetic basis of long QT and short QT syndromes: a mutation update. Hum Mutat (2009) 2.54
Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci. Am J Hum Genet (2012) 2.53
Severe disease expression of cardiac troponin C and T mutations in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol (2004) 2.40
Inherited cardiomyopathies. N Engl J Med (2011) 2.25
Genetically determined height and coronary artery disease. N Engl J Med (2015) 2.24
Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes. Diabetes (2011) 2.21
Secretory phospholipase A(2)-IIA and cardiovascular disease: a mendelian randomization study. J Am Coll Cardiol (2013) 2.18
Identification of novel interactions between domains of Myosin binding protein-C that are modulated by hypertrophic cardiomyopathy missense mutations. Circ Res (2002) 2.13
Reduced phospholamban phosphorylation is associated with impaired relaxation in left ventricular myocytes from neuronal NO synthase-deficient mice. Circ Res (2007) 2.07
Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci. Am J Hum Genet (2012) 1.96
Metabolic modulator perhexiline corrects energy deficiency and improves exercise capacity in symptomatic hypertrophic cardiomyopathy. Circulation (2010) 1.96
Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy. J Am Coll Cardiol (2003) 1.84
Identification and functional characterization of cardiac troponin I as a novel disease gene in autosomal dominant dilated cardiomyopathy. Circ Res (2009) 1.83
Familial dilated cardiomyopathy caused by an alpha-tropomyosin mutation: the distinctive natural history of sarcomeric dilated cardiomyopathy. J Am Coll Cardiol (2010) 1.83
Dilated and hypertrophic cardiomyopathy mutations in troponin and alpha-tropomyosin have opposing effects on the calcium affinity of cardiac thin filaments. Circ Res (2007) 1.80
Personalized medicine: hope or hype? Eur Heart J (2012) 1.80
Mutations of the light meromyosin domain of the beta-myosin heavy chain rod in hypertrophic cardiomyopathy. Circ Res (2002) 1.77
A genome-wide association search for type 2 diabetes genes in African Americans. PLoS One (2012) 1.72
Novel associations of CPS1, MUT, NOX4, and DPEP1 with plasma homocysteine in a healthy population: a genome-wide evaluation of 13 974 participants in the Women's Genome Health Study. Circ Cardiovasc Genet (2009) 1.71
Dilated cardiomyopathy mutations in three thin filament regulatory proteins result in a common functional phenotype. J Biol Chem (2005) 1.70
Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion. Trends Genet (2003) 1.62
Subunit composition of AMPK trimers present in the cytokinetic apparatus: Implications for drug target identification. Cell Cycle (2012) 1.57
Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging. Circulation (2007) 1.54
Evidence from human myectomy samples that MYBPC3 mutations cause hypertrophic cardiomyopathy through haploinsufficiency. Circ Res (2009) 1.52
Shared genetic susceptibility to ischemic stroke and coronary artery disease: a genome-wide analysis of common variants. Stroke (2013) 1.51
Embryonic expression of AMPK γ subunits and the identification of a novel γ2 transcript variant in adult heart. J Mol Cell Cardiol (2012) 1.45
Blood pressure loci identified with a gene-centric array. Am J Hum Genet (2011) 1.44
The genetic basis of Brugada syndrome: a mutation update. Hum Mutat (2009) 1.44
Reviews of translational medicine and genomics in cardiovascular disease: new disease taxonomy and therapeutic implications cardiomyopathies: therapeutics based on molecular phenotype. J Am Coll Cardiol (2007) 1.42
DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model. Eur Heart J (2010) 1.40
Alterations in thin filament regulation induced by a human cardiac troponin T mutant that causes dilated cardiomyopathy are distinct from those induced by troponin T mutants that cause hypertrophic cardiomyopathy. J Biol Chem (2002) 1.37
Fumarate is cardioprotective via activation of the Nrf2 antioxidant pathway. Cell Metab (2012) 1.35
Reduced inotropic reserve and increased susceptibility to cardiac ischemia/reperfusion injury in phosphocreatine-deficient guanidinoacetate-N-methyltransferase-knockout mice. Circulation (2005) 1.33
Supranormal myocardial creatine and phosphocreatine concentrations lead to cardiac hypertrophy and heart failure: insights from creatine transporter-overexpressing transgenic mice. Circulation (2005) 1.30
Genome-wide mapping of susceptibility to coronary artery disease identifies a novel replicated locus on chromosome 17. PLoS Genet (2006) 1.29
Disease pathways and novel therapeutic targets in hypertrophic cardiomyopathy. Circ Res (2011) 1.28
Mutations in fast skeletal troponin I, troponin T, and beta-tropomyosin that cause distal arthrogryposis all increase contractile function. FASEB J (2006) 1.27
Homocysteine and coronary heart disease: meta-analysis of MTHFR case-control studies, avoiding publication bias. PLoS Med (2012) 1.27
Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives. Hum Mutat (2009) 1.26
Genome-wide association study for circulating levels of PAI-1 provides novel insights into its regulation. Blood (2012) 1.26
A novel common single nucleotide polymorphism in the promoter region of the C-reactive protein gene associated with the plasma concentration of C-reactive protein. Atherosclerosis (2005) 1.26
Genome-wide linkage analysis of electrocardiographic and echocardiographic left ventricular hypertrophy in families with hypertension. Eur Heart J (2008) 1.25
Truncated estrogen receptor alpha 46-kDa isoform in human endothelial cells: relationship to acute activation of nitric oxide synthase. Circulation (2003) 1.25
Genotype at the -174G/C polymorphism of the interleukin-6 gene is associated with common carotid artery intimal-medial thickness: family study and meta-analysis. Stroke (2005) 1.16
The role of sarcomere gene mutations in patients with idiopathic dilated cardiomyopathy. Eur J Hum Genet (2009) 1.15
The effect of mutations in alpha-tropomyosin (E40K and E54K) that cause familial dilated cardiomyopathy on the regulatory mechanism of cardiac muscle thin filaments. J Biol Chem (2007) 1.15
Characterization of the role of gamma2 R531G mutation in AMP-activated protein kinase in cardiac hypertrophy and Wolff-Parkinson-White syndrome. Am J Physiol Heart Circ Physiol (2005) 1.14
Apolipoprotein(a) genetic sequence variants associated with systemic atherosclerosis and coronary atherosclerotic burden but not with venous thromboembolism. J Am Coll Cardiol (2012) 1.14
AMP-activated protein kinase phosphorylates cardiac troponin I and alters contractility of murine ventricular myocytes. Circ Res (2012) 1.14
A mutation in the mitochondrial fission gene Dnm1l leads to cardiomyopathy. PLoS Genet (2010) 1.13
Living without creatine: unchanged exercise capacity and response to chronic myocardial infarction in creatine-deficient mice. Circ Res (2013) 1.13
Association between common polymorphisms of the proopiomelanocortin gene and body fat distribution: a family study. Diabetes (2005) 1.11
Investigation of a transgenic mouse model of familial dilated cardiomyopathy. J Mol Cell Cardiol (2010) 1.10